{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:24:35Z","timestamp":1719275075457},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,24]]},"DOI":"10.7759\/cureus.63045","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T15:43:33Z","timestamp":1719243813000},"source":"Crossref","is-referenced-by-count":0,"title":["Pulmonary Sarcomatoid Carcinoma: What Makes This Rare Lung Cancer So Challenging?"],"prefix":"10.7759","author":[{"given":"Badr","family":"Kharouaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amine","family":"Hayoune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Gartini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meriem","family":"Rhazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf","family":"Thouil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatim","family":"Kouismi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2011.09.001","article-title":"Lung cancer: epidemiology, etiology, and prevention","volume":"32","author":"Dela Cruz CS","year":"2011","unstructured":"Dela Cruz CS, Tanoue LT, Matthay RA. Lung cancer: epidemiology, etiology, and prevention. Clin Chest Med. 2011, 32:605-44. 10.1016\/j.ccm.2011.09.001","journal-title":"Clin Chest Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23468","article-title":"Pulmonary sarcomatoid carcinoma: University of Cincinnati experience","volume":"9","author":"Karim NA","year":"2018","unstructured":"Karim NA, Schuster J, Eldessouki I, et al.. Pulmonary sarcomatoid carcinoma: University of Cincinnati experience. Oncotarget. 2018, 9:4102-8. 10.18632\/oncotarget.23468","journal-title":"Oncotarget"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920950207","article-title":"Pulmonary sarcomatoid carcinoma: progress, treatment and expectations","volume":"12","author":"Li X","year":"2020","unstructured":"Li X, Wu D, Liu H, Chen J. Pulmonary sarcomatoid carcinoma: progress, treatment and expectations. Ther Adv Med Oncol. 2020, 12:1758835920950207. 10.1177\/1758835920950207","journal-title":"Ther Adv Med Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.56345\/ijrdv10n113","article-title":"Pulmonary cancer","volume":"10","author":"Zanaj V","year":"2023","unstructured":"Zanaj V,  Vogli K. Pulmonary cancer. Interdisciplinary Journal of Research and Development. 2023, 10:96. 10.56345\/ijrdv10n113","journal-title":"Interdisciplinary Journal of Research and Development"},{"key":"ref5","article-title":"Pulmonary sarcomatoid carcinoma","volume":"7","author":"Sharma M","year":"2018","unstructured":"Sharma M. Pulmonary sarcomatoid carcinoma. Int. J Med. Dent.. 2018, 7:1684-5.","journal-title":"Int. J Med. Dent."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-11-252","article-title":"Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases","volume":"11","author":"Huang SY","year":"2013","unstructured":"Huang SY, Shen SJ, Li XY. Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases. World J Surg Oncol. 2013, 11:252. 10.1186\/1477-7819-11-252","journal-title":"World J Surg Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000101","article-title":"Characteristics and prognostic analysis of 69 patients with pulmonary sarcomatoid carcinoma","volume":"39","author":"Lin Y","year":"2016","unstructured":"Lin Y, Yang H, Cai Q, et al.. Characteristics and prognostic analysis of 69 patients with pulmonary sarcomatoid carcinoma. Am J Clin Oncol. 2016, 39:215-22. 10.1097\/COC.0000000000000101","journal-title":"Am J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.136920","article-title":"Sarcomatoid carcinoma of the lung: a model of resistance of chemotherapy","volume":"6","author":"Ouziane I","year":"2014","unstructured":"Ouziane I, Boutayeb S, Mrabti H, Lalya I, Rimani M, Errihani H. Sarcomatoid carcinoma of the lung: a model of resistance of chemotherapy. N Am J Med Sci. 2014, 6:342-5. 10.4103\/1947-2714.136920","journal-title":"N Am J Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2017.245","article-title":"Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma","volume":"33","author":"Sim JK","year":"2018","unstructured":"Sim JK, Chung SM, Choi JH, et al.. Clinical and molecular characteristics of pulmonary sarcomatoid carcinoma. Korean J Intern Med. 2018, 33:737-44. 10.3904\/kjim.2017.245","journal-title":"Korean J Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.JTO.0000437008.00554.90","article-title":"Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma","volume":"8","author":"Vieira T","year":"2013","unstructured":"Vieira T, Girard N, Ung M, et al.. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma. J Thorac Oncol. 2013, 8:1574-7. 10.1097\/01.JTO.0000437008.00554.90","journal-title":"J Thorac Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2016.03.001","article-title":"Characteristics and clinical outcomes of sarcomatoid carcinoma of the lung","volume":"17","author":"Ung M","year":"2016","unstructured":"Ung M, Rouquette I, Filleron T, et al.. Characteristics and clinical outcomes of sarcomatoid carcinoma of the lung. Clin Lung Cancer. 2016, 17:391-7. 10.1016\/j.cllc.2016.03.001","journal-title":"Clin Lung Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-019-0991-y","article-title":"Gingival metastasis of a mediastinal pulmonary sarcomatoid carcinoma: a case report","volume":"14","author":"Qin Z","year":"2019","unstructured":"Qin Z, Huang B, Yu G, Zheng Y, Zhao K. Gingival metastasis of a mediastinal pulmonary sarcomatoid carcinoma: a case report. J Cardiothorac Surg. 2019, 14:161. 10.1186\/s13019-019-0991-y","journal-title":"J Cardiothorac Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181804302","article-title":"Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases","volume":"32","author":"Mochizuki T","year":"2008","unstructured":"Mochizuki T, Ishii G, Nagai K, et al.. Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases. Am J Surg Pathol. 2008, 32:1727-35. 10.1097\/PAS.0b013e3181804302","journal-title":"Am J Surg Pathol"},{"key":"ref14","article-title":"A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples","volume":"32","author":"Pelosi G","year":"2012","unstructured":"Pelosi G, Melotti F, Cavazza A, et al.. A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples. Anticancer Res. 2012, 32:1463-73.","journal-title":"Anticancer Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14111","article-title":"Rapid sarcomatoid transformation of lung squamous cell carcinoma after neoadjuvant therapy: a case report","volume":"40","author":"Arshi J","year":"2020","unstructured":"Arshi J, Sauer M, Yin F. Rapid sarcomatoid transformation of lung squamous cell carcinoma after neoadjuvant therapy: a case report. Anticancer Res. 2020, 40:1625-9. 10.21873\/anticanres.14111","journal-title":"Anticancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/LCTT.S186779","article-title":"Approaches to tumor classification in pulmonary sarcomatoid carcinoma","volume":"10","author":"Baldovini C","year":"2019","unstructured":"Baldovini C, Rossi G, Ciarrocchi A. Approaches to tumor classification in pulmonary sarcomatoid carcinoma. Lung Cancer (Auckl). 2019, 10:131-49. 10.2147\/LCTT.S186779","journal-title":"Lung Cancer (Auckl)"},{"key":"ref17","article-title":"Spindle cell carcinoma of the lung. A clinicopathologic study of three cases","volume":"67","author":"Matsui K","year":"19911","unstructured":"Matsui K, Kitagawa M. Spindle cell carcinoma of the lung. A clinicopathologic study of three cases. Cancer. 19911, 67:2361-7.","journal-title":"Cancer"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(197012)26:6<1311::AID-CNCR2820260618>3.0.CO;2-C","article-title":"Spindle-cell variant of squamous carcinoma. A light and electron microscopic study of 13 cases","volume":"26","author":"Lichtiger B","year":"1970","unstructured":"Lichtiger B, Mackay B, Tessmer CF. Spindle-cell variant of squamous carcinoma. A light and electron microscopic study of 13 cases. Cancer. 1970, 26:1311-20.","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/77.2.123","article-title":"The World Health Organization histological typing of lung tumours. Second edition","volume":"77","year":"1982","unstructured":"The World Health Organization histological typing of lung tumours. Second edition. Am J Clin Pathol. 1982, 77.123-36. 10.1093\/ajcp\/77.2.123","journal-title":"Am J Clin Pathol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"22","author":"Borghaei H","year":"2015","unstructured":"Borghaei H, Paz-Ares L, Horn L, et al.. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015, 22:1627-39. 10.1056\/NEJMoa1507643","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.04.020","article-title":"Deep sequencing analysis reveals that KRAS mutation is a marker of poor prognosis in patients with pulmonary sarcomatoid carcinoma","volume":"11","author":"Lococo F","year":"2016","unstructured":"Lococo F, Gandolfi G, Rossi G, et al.. Deep sequencing analysis reveals that KRAS mutation is a marker of poor prognosis in patients with pulmonary sarcomatoid carcinoma. J Thorac Oncol. 2016, 11:1282-92. 10.1016\/j.jtho.2016.04.020","journal-title":"J Thorac Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S169074","article-title":"CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer","volume":"13","author":"Chen J","year":"2018","unstructured":"Chen J, He Q, Liu J, et al.. CD8+ tumor-infiltrating lymphocytes as a novel prognostic biomarker in lung sarcomatoid carcinoma, a rare subtype of lung cancer. Cancer Manag Res. 2018, 13:3505-11. 10.2147\/CMAR.S169074","journal-title":"Cancer Manag Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/262878-pulmonary-sarcomatoid-carcinoma-what-makes-this-rare-lung-cancer-so-challenging","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T15:43:40Z","timestamp":1719243820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/262878-pulmonary-sarcomatoid-carcinoma-what-makes-this-rare-lung-cancer-so-challenging"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.63045","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,24]]}}}